关于循环中的细胞因子与结直肠癌的因果关系的门德尔随机化研究
Youqian Kong1, Xiaoyu Wang1, Hongyun Xu1
1Graduate School, Heilongjiang University of Chinese Medicine, Harbin, China.
PloS one
|December 14, 2023
概括
这项研究使用遗传数据证实,某些循环的细胞因子因果上会增加结肠直肠癌 (CRC) 风险,而一种细胞因子会降低. 这些发现有助于更好地了解CRC的发展和潜在的新疗法.
科学领域:
- 遗传学 遗传学 是一个
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 循环细胞因子与结直肠癌 (CRC) 有关,但因果关系尚不清楚.
- 门德尔随机化 (MR) 用于研究细胞因子和CRC之间的机械联系.
- 基因数据分析对于理解复杂疾病病因至关重要.
研究的目的:
- 通过使用孟德尔随机化来确定循环细胞因子对结直肠癌 (CRC) 风险的因果关系.
- 为了确定影响CRC发育的特定细胞因子.
- 基于细胞因子参与,探索CRC的潜在治疗点.
主要方法:
- 一项两样本的门德尔随机化 (MR) 研究在欧洲祖先的个人中进行.
- 使用了公开可用的全基因组关联研究 (GWAS) 统计数据.
- 应用了多种MR分析方法,包括IVW,MR-Egger和MR-PRESSO,以评估因果关系并排除性.
主要成果:
- 基因预测的较高水平的血管内皮生长因子,白内素-12p70,白内素-13,白内素-10和白内素-7与增加的CRC风险有关.
- 巨细胞殖民地刺激因子显示出与CRC风险的负因果关系.
- 灵敏度分析证实了研究结果的可靠性和没有显著的水平性.
结论:
- 这项研究确定了特定循环细胞因子水平与结直肠癌 (CRC) 风险之间的因果关系.
- 这些发现有助于更深入地了解CRC病原体.
- 已识别的细胞因子协会为新型CRC治疗策略提供了潜在的目标.
相关概念视频
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
02:40Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...